JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266620

Human MRFAP1 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

MRFAP1 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1.

View Alternative Names

MOFA1_HUMAN, MORF4 family-associated protein 1, Mof4 family associated protein 1, Mrfap1, OTTHUMP00000155159, OTTHUMP00000217763, PAM14, PGR1, Protein PGR1, Protein associated with MRG 14 kDa, Protein associated with MRG of 14 kDa, T cell activation protein

1 Images
Sanger Sequencing - Human MRFAP1 knockout HEK-293T cell line (AB266620)
  • Sanger seq

Unknown

Sanger Sequencing - Human MRFAP1 knockout HEK-293T cell line (AB266620)

Homozygous : Insertion of the selection cassette in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266620-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266620 Human MRFAP1 knockout HEK-293T cell line", "number":"AB266620-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266620-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266620 Human MRFAP1 knockout HEK-293T cell line", "number":"AB266620-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
MRFAP1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MRFAP1 (Morf4 family-associated protein 1) plays a role in chromatin remodeling and transcription regulation. It physically interacts with the tumor suppressor MORF4L1 (also known as Mortality Factor 4-like 1) and other members of the MRG15 complex. MRFAP1 which has a molecular weight of approximately 13.5 kDa is predominantly expressed in the nucleus of cells. Its expression is observed in various tissues but it's notably high in the testes and heart.
Biological function summary

The protein MRFAP1 contributes to the regulation of transcription by serving as a scaffold linking histone acetylation and methylation. This action fosters interactions within the MRN complex which includes MRG15. Through these connections MRFAP1 influences chromatin structure and as a result gene expression. Its role is significant in regulating cellular senescence and differentiation.

Pathways

MRFAP1 is actively involved in the chromatin modification pathway. This pathway coordinates with the action of other proteins such as MRG15 to alter histone acetylation levels impacting transcriptional regulation. Additionally MRFAP1 engages in the DNA damage repair pathway assisting another protein known as RNF8. These interactions anchor MRFAP1 in pivotal cellular functions relating to genetic stability.

MRFAP1 has associations with cancer and certain chromatin-related disorders. Cancer research highlights MRFAP1's contribution to tumorigenesis where changes in its function can disrupt chromatin remodeling leading to unchecked cell proliferation. Furthermore alterations in MRFAP1 can affect its interaction with MORF4L1 influencing cancer progression. The link between MRFAP1 and these proteins provides insights into potential therapeutic targets for treating these conditions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com